Allurion Technologies (ALURD) Capital Expenditures (2022 - 2024)

Allurion Technologies (ALURD) Capital Expenditures (2022 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Abbott Laboratories 186.78 Bn 179.48 Bn 6.27 Bn 399.00 Mn
2 Stryker 131.95 Bn 129.07 Bn 3.81 Bn 166.00 Mn
3 Medtronic 111.27 Bn 102.05 Bn 6.41 Bn 488.00 Mn
4 Boston Scientific 68.58 Bn 67.13 Bn 3.61 Bn 177.00 Mn
5 Edwards Lifesciences 48.31 Bn 44.63 Bn 1.29 Bn 64.90 Mn
6 GE HealthCare Technologies 29.23 Bn 26.94 Bn 1.98 Bn 178.00 Mn
7 Dexcom 28.90 Bn 27.78 Bn 750.30 Mn 76.60 Mn
8 Smith & Nephew 28.19 Bn 27.62 Bn - -
9 Koninklijke Philips 24.33 Bn 21.29 Bn 2.01 Bn -83.07 Mn
10 Allurion Technologies 60.75 Mn 55.69 Mn 1.23 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2024 580,000.00
Sep 30, 2024 580,000.00
Jun 30, 2024 -73,000.00
Jun 30, 2024 -73,000.00
Mar 31, 2024 104,000.00
Mar 31, 2024 104,000.00
Dec 31, 2023 1.34 Mn
Dec 31, 2023 1.34 Mn
Sep 30, 2023 105,000.00
Sep 30, 2023 105,000.00
Jun 30, 2023 -112,000.00
Jun 30, 2023 -112,000.00
Mar 31, 2023 277,000.00
Mar 31, 2023 277,000.00
Dec 31, 2022 459,000.00
Dec 31, 2022 459,000.00
Sep 30, 2022 -157,000.00
Sep 30, 2022 -157,000.00